ATRA Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. (ATRA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $3.2M.
Where they traded
Last open-market purchase: September 4, 2026 , by Cherry Brian N .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Cherry Brian N | Director | Buy | 104,166 | $9.60 | $1000.0K | 166,486 | |
| Nguyen AnhCo | President and CEO | Sell | 5,062 | $8.08 | $40.9K | 132,775 −3.7% of holding | |
| Nguyen AnhCo | President and CEO | Sell | 5,241 | $9.13 | $47.8K | 137,837 −3.7% of holding | |
| Grant-Huerta Yanina | Chief Accounting Officer | Sell | 2,414 | $9.13 | $22.0K | 49,636 −4.6% of holding | |
| EcoR1 Capital, LLC | 10% Owner | Buy | 507,407 | $9.35 | $4.7M | 1,552,000 | |
| Sell | 313,446 | $10.10 | $3.2M | 1,011,000 −23.7% of holding | |||
| Nguyen AnhCo 4 fills | President and CEO | Sell | 2,996 | $5.09 | $15.2K | 64,776 −4.4% of holding | |
| Grant-Huerta Yanina 4 fills | Chief Accounting Officer | Sell | 2,104 | $5.08 | $10.7K | 33,830 −5.9% of holding | |
| Sell | 80,554 | $6.07 | $489.0K | 1,324,446 −5.7% of holding | |||
| Nguyen AnhCo 2 fills | President and CEO | Sell | 2,915 | $13.19 | $38.4K | 65,030 −4.3% of holding | |
| Grant-Huerta Yanina 3 fills | Chief Accounting Officer | Sell | 1,804 | $13.19 | $23.8K | 33,613 −5.1% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.